From January 19, 2024 to March 31, 2024, the company has repurchased 1,496,000 shares, representing 0.32% for CNY 84.75 million. With this, the company has completed the repurchase of 1,496,000 shares, representing 0.32% for CNY 84.75 million under the buyback announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.03 CNY | -1.60% | +6.65% | -39.22% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.22% | 2.48B | |
-22.04% | 8.54B | |
+68.95% | 4.32B | |
-0.82% | 2.53B | |
-9.36% | 1.9B | |
-18.74% | 1.59B | |
-40.70% | 1.23B | |
+13.38% | 1.13B | |
+16.15% | 994M | |
-4.52% | 921M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.